Agnė Vaitkevičienė

EuropaBio and P-BIO launch the National Associations Council Summit 2021 Building on Biotechnology: From vaccines to economic Growth for Europe. May 10.

The National Associations Council of EuropaBio is pleased to launch its 2021 Summit ‘Building on Biotechnology: From vaccines to economic Growth for Europe’ being hosted on May 10. This inaugural Summit for the National Associations Council (NAC) will address how national priorities and synergies should be used to create an economic recovery pathway for Europe…

LBTA participated in the international congregation of biotechnology sector representatives

Agne Vaitkeviciene, Executive Director of Lithuania’s Biotechnology Association, during Women Entrepreneurs Conclave, shared Lithuania’s initiatives taken to boost women entrepreneurship in the biotechnology sector and presented the Women in Biotech platform. Privilege to discuss the common challenges together with role models of the sector in India.  

ECHAlliance host Ecosystem Coordinator Call to Connect the dots with our Coordinators

In February coordinator call was set up with the ECHAlliance Coordinators in order to get them better connected with each other as ECHAlliance rapidly grows. Over the last 2 years 25 new Ecosystems joined our network and more joining each month. The theme this time was about collaboration and connecting the dots within the network,…

Scientists have developed the first Lithuanian antibody diagnostics kit against SARS-CoV-2

Dr. Rimantas Slibinskas, the head of UAB Baltymas, last summer said that in an optimistic scenario, the Lithuanian COVID-19 antibody detection test can be expected at the end of the year. The latest news from this biotechnology company and their partners – UAB Imunodiagnostica confirms that the prognosis was correct – the first Lithuanian diagnostic…

Biotechnology Sector Is Ready for a Leap and Waiting for a Strategic Approach from the State

In 2019, companies, working in the Lithuanian biotechnology sector, have shown a growth of 24% in revenue, exceeding 1 billion Eur. The sector is expected to maintain the same rapid pace in 2020 as well. However, entrepreneurs and scientists, working in the industry believe that the future growth should be even faster, while the pandemic,…

Biotech startup DROPLET GENOMICS raises €1 million from PRACTICA CAPITAL to commercialize droplet microfluidics technology

Vilnius, Lithuania, January 27, 2021 – Droplet Genomics, a Lithuanian biotech startup, has today announced that it has raised a total of €1M in a Seed funding round led by Practica Capital, with contribution from Angel investors. Droplet Genomics is a Lithuanian biotech startup that aims to commercialize droplet microfluidics technology. Owing to its unparalleled…

Science and business professionals presented the development of bioeconomy and life sciences in Lithuanian regions

On 15 October, the Lithuanian Biotechnology Association started an event tour of Lithuanian regions “Bioeconomy and Life Sciences Development Opportunities in Lithuanian Regions”. Researchers and biotechnology industry representatives invited regional municipalities and local businesses to discuss regional involvement in the development of innovative technologies. The bioeconomy and life sciences play an important role in Lithuania’s…

“Bioeconomy and Life Sciences Development Opportunities in Lithuanian Regions” event tour has successfully reached its end

The event tour of Lithuanian regions “Bioeconomy and Life Sciences Development Opportunities in Lithuanian Regions”, organised by the Lithuanian Biotechnology Association, reached the finnish on the 13th of November. After the first visit to Telsiai, due to the spread the COVID-19 infection, it was decided to transfer the tour events to the remote format, thus…

Northway Biotech opens new biopharmaceutical manufacturing facility in Greater Boston Area

Waltham, MA, US – January 20, 2021 – Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art, cGMP manufacturing site in Europe, announced at the virtual grand opening ceremony today, the opening of its new 30,000 square-foot process development and cGMP manufacturing site in Waltham,…

Northway Biotechpharma announces company name change to Northway Biotech

Vilnius, Lithuania, and Waltham, MA, US – December 9, 2020 – Northway Biotechpharma, providing end-to-end contract drug development and manufacturing (CDMO) services, announces brand name change to Northway Biotech. Along with the tradename change, Dr. Vladas Algirdas Bumelis also returns to the helm as Chief Executive Officer at the company he founded. “We are expanding…